期刊
EMERGING INFECTIOUS DISEASES
卷 27, 期 12, 页码 3178-3180出版社
CENTERS DISEASE CONTROL & PREVENTION
DOI: 10.3201/eid2712.211772
关键词
-
资金
- National Institute of Allergy and Infectious Diseases of the National Institutes of Health [U01AI151797]
- National Research Council of Thailand [N35A640037]
In vitro testing of serum samples from CoronaVac vaccine recipients showed that neutralizing antibodies provided short-term protection against the original virus strain and limited protection against variants of concern. These findings support the use of vaccine boosters, particularly in regions where variants of concern are circulating.
In vitro determination of severe acute respiratory syndrome coronavirus 2 neutralizing antibodies induced in serum samples from recipients of the CoronaVac vaccine showed a short protection period against the original virus strain and limited protection against variants of concern. These data provide support for vaccine boosters, especially variants of concern circulate.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据